
-
Landslide-prone Nepal tests AI-powered warning system
-
El Salvador parliament adopts reform to allow Bukele to run indefinitely
-
What are all these microplastics doing to our brains?
-
Zverev rallies in Toronto to claim milestone 500th ATP match win
-
Farrell says debate over Australia as Lions destination 'insulting'
-
After stadium delays, African Nations Championship kicks off
-
US tech titan earnings rise on AI as economy roils
-
Nvidia says no 'backdoors' in chips as China questions security
-
Wallabies' Tizzano absent from third Lions Test after online abuse
-
Famed union leader Dolores Huerta urges US to mobilize against Trump
-
Richardson, Lyles ease through 100m heats at US trials
-
Correa returning to Astros in blockbuster MLB trade from Twins
-
Trump orders tariffs on dozens of countries in push to reshape global trade
-
Trump to build huge $200mn ballroom at White House
-
Heathrow unveils £49 bn expansion plan for third runway
-
'Peaky Blinders' creator to pen new James Bond movie: studio
-
Top seed Gauff rallies to reach WTA Montreal fourth round
-
Amazon profits surge 35% but forecast sinks share price
-
Gas workers uncover 1,000-year-old mummy in Peru
-
Brazil vows to fight Trump tariff 'injustice'
-
Michelsen stuns Musetti as Ruud rallies in Toronto
-
Oscars group picks 'A Star is Born' producer as new president
-
Global stocks mostly fall ahead of big Trump tariff deadline
-
Apple profit beats forecasts on strong iPhone sales
-
Michelsen stuns Musetti at ATP Toronto Masters
-
Peru's president rejects court order on police amnesty
-
Google must open Android to rival app stores: US court
-
Amazon profits surge 35% as AI investments drive growth
-
Zelensky urges allies to seek 'regime change' in Russia
-
Trump envoy to inspect Gaza aid as pressure mounts on Israel
-
US theater and opera legend Robert Wilson dead at 83
-
EA shooter 'Battlefield 6' to appear in October
-
Heavyweight shooter 'Battlefield 6' to appear in October
-
Justin Timberlake says he has Lyme disease
-
Atkinson and Tongue strike as India struggle in England decider
-
US theater and opera auteur Bob Wilson dead at 83
-
Trump envoy to visit Gaza as pressure mounts on Israel
-
In Darwin's wake: Two-year global conservation voyage sparks hope
-
Microsoft valuation surges above $4 trillion as AI lifts stocks
-
Verstappen quells speculation by committing to Red Bull for 2026
-
Study reveals potato's secret tomato past
-
Trump's envoy in Israel as Gaza criticism mounts
-
Squiban solos to Tour de France stage win, Le Court maintains lead
-
Max Verstappen confirms he is staying at Red Bull next year
-
Mitchell keeps New Zealand on top against Zimbabwe
-
Vasseur signs new contract as Ferrari team principal
-
French cities impose curfews for teens to curb crime
-
Seals sing 'otherworldly' songs structured like nursery rhymes
-
India captain Gill run out in sight of Gavaskar record
-
Trump's global trade policy faces test, hours from tariff deadline
RBGPF | 0.69% | 74.94 | $ | |
CMSC | 1.09% | 22.85 | $ | |
NGG | 0.28% | 70.39 | $ | |
SCU | 0% | 12.72 | $ | |
RYCEF | 7.62% | 14.18 | $ | |
RELX | 0.21% | 51.89 | $ | |
AZN | -4.79% | 73.09 | $ | |
GSK | -4.9% | 37.15 | $ | |
BP | -0.31% | 32.15 | $ | |
BTI | 0.97% | 53.68 | $ | |
RIO | 0.47% | 59.77 | $ | |
SCS | 0% | 10.33 | $ | |
CMSD | 0.9% | 23.27 | $ | |
BCC | -1.29% | 83.81 | $ | |
JRI | 0.15% | 13.13 | $ | |
VOD | -2.31% | 10.81 | $ | |
BCE | -0.86% | 23.33 | $ |

Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
C.Hamad--SF-PST